Pharmacogenomics (PGx)

Pharmacogenomics

Pharmacogenomic testing is the testing of certain genes to determine how individuals might react to specific medications. With insight derived from pharmacogenetic testing, healthcare providers may decrease the need for trial and error dosing and might substantially reduce the risk of adverse drug events. Learn more about Pharmacogenetic Testing at https://www.fda.gov/drugs/science-and-research-drugs/table-pharmacogenomic-biomarkers-drug-labeling

Psychiatric PGx Test Panel

Many of patients with depression do not respond to their first anti depression medications. Response to these medications may be under genetic influence. In addition, the genetic profile of individuals may explain the differences in response to some of anti-seizure, anti- anxiety medications as well as other medications commonly used to treat neurological and psychiatric conditions.

Cardiovascular PGx Test Panel

Many cardiovascular medications are metabolized by certain cytochromes in the liver. The exact same dose of a medication can produce different results in different individuals. This inter-individual variability can be due to genetics of such cytochromes or other genetic pathways. Determining the genetic make-up of an individual can help with precision prescribing of the medications.

Pain Management PGx Test Panel

Commonly used pain medications such as narcotics and over the counter pain medications are under influence of genetic make-up of individuals. A standard dose of a pain medication such as codeine may not be effective in one individual while the exact same dose may be toxic for another individual based on their genetic profile. Therefore, determining the genetic make-up of an individual can help with precision prescribing of the medications.

Pharmacogenomics (PGx)